1-2 of 2
Karl-Heinz Pfluger
Close
Sort by
Journal Articles

Low-Dose Decitabine Vs Best Supportive Care In Older Patients With AML and Low Blast Counts: Results Of a Subgroup Analysis Of The Randomized Phase III Study 06011 Of The EORTC Leukemia Cooperative Group and German MDS Study Group

Heiko Becker, MD, Stefan Suciu, PhD, Björn Rüter, MD, Uwe Platzbecker, MD, PhD, Aristoteles Giagounidis, MD, Dominik Selleslag, MD, Boris Labar, MD, PhD, Ulrich Germing, MD, Helmut R. Salih, MD, Petra Muus, MD, PhD, Karl-Heinz Pflüger, MD, Anne Hagemeijer, MD, PhD, Hans-Eckart Schaefer, MD, Frédéric Baron, MD, PhD, Arnold Ganser, MD, Carlo Aul, MD, Theo de Witte, MD, Pierre W. Wijermans, MD, Michael Lübbert, MD
Journal: Blood
Blood (2013) 122 (21): 1452.
https://doi.org/10.1182/blood.V122.21.1452.1452
Published: 2013
Journal Articles

Comprehensive Risk Factor Analysis in 939 Adults with Acute Myeloid Leukemia Receiving Risk Stratified Post-Remission Therapy: Results of the Prospective Randomized AML96 Trial of the German Study Initiative Leukemia (DSIL).

Gerhard Ehninger, Martin Bornhaeuser, Christian Thiede, Walter E. Aulitzky, Heinrich Bodenstein, Bernd Dorken, Hermann Einsele, Martin Gramatzki, Mathias Hanel, Gisela Helm, Anthony D. Ho, Andreas Jakob, Ulrich Krumpelmann, Lothar Leimer, Hartmut Link, Stefan Mahlmann, Andreas Neubauer, Karl-Heinz Pfluger, Mathias Sandmann, Kerstin Schafer-Eckart, Norbert Schmitz, Ulrich S. Schuler, Silke Soucek, Reingard Stuhlmann, Hans-Joachim Tischler, Thomas Wagner, Hannes Wandt, Thomas Illmer, Markus A. Schaich
Journal: Blood
Blood (2007) 110 (11): 1847.
https://doi.org/10.1182/blood.V110.11.1847.1847
Published: 2007